Suppr超能文献

1型人类免疫缺陷病毒包膜糖蛋白的截短可使莫洛尼鼠白血病病毒颗粒高效假型化,并将基因转移至CD4+细胞中。

Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.

作者信息

Mammano F, Salvatori F, Indraccolo S, De Rossi A, Chieco-Bianchi L, Göttlinger H G

机构信息

Institute of Oncology, Interuniversity Center for Cancer Research, University of Padua, Italy.

出版信息

J Virol. 1997 Apr;71(4):3341-5. doi: 10.1128/JVI.71.4.3341-3345.1997.

Abstract

Human immunodeficiency virus type 1 (HIV-1) can readily accept envelope (Env) glycoproteins from distantly related retroviruses. However, we previously showed that the HIV-1 Env glycoprotein complex is excluded even from particles formed by the Gag proteins of another lentivirus, visna virus, unless the matrix domain of the visna virus Gag polyprotein is replaced by that of HIV-1. We also showed that the integrity of the HIV-1 matrix domain is critical for the incorporation of wild-type HIV-1 Env protein but not for the incorporation of a truncated form which lacks the 144 C-terminal amino acids of the cytoplasmic domain of the transmembrane glycoprotein. We report here that the C-terminal truncation of the transmembrane glycoprotein also allows the efficient incorporation of HIV-1 Env proteins into viral particles formed by the Gag proteins of the widely divergent Moloney murine leukemia virus (Mo-MLV). Additionally, pseudotyping of a Mo-MLV-based vector with the truncated rather than the full-length HIV-1 Env allowed efficient transduction of human CD4+ cells. These results establish that Mo-MLV-based vectors can be used to target cells susceptible to infection by HIV-1.

摘要

1型人类免疫缺陷病毒(HIV-1)能够轻易接纳来自远亲逆转录病毒的包膜(Env)糖蛋白。然而,我们之前的研究表明,即便使用另一种慢病毒——维斯纳病毒的Gag蛋白形成病毒颗粒,HIV-1 Env糖蛋白复合体也会被排除在外,除非用HIV-1的基质结构域替换维斯纳病毒Gag多聚蛋白的基质结构域。我们还发现,HIV-1基质结构域的完整性对于野生型HIV-1 Env蛋白的掺入至关重要,但对于掺入缺少跨膜糖蛋白胞质结构域144个C末端氨基酸的截短形式则并非如此。我们在此报告,跨膜糖蛋白的C末端截短还能使HIV-1 Env蛋白高效掺入由广泛不同的莫洛尼鼠白血病病毒(Mo-MLV)的Gag蛋白形成的病毒颗粒中。此外,用截短的而非全长的HIV-1 Env对基于Mo-MLV的载体进行假型化,能够高效转导人CD4+细胞。这些结果表明,基于Mo-MLV的载体可用于靶向易受HIV-1感染的细胞。

相似文献

引用本文的文献

本文引用的文献

1
Development of HIV vectors for anti-HIV gene therapy.用于抗HIV基因治疗的HIV载体的开发。
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11395-9. doi: 10.1073/pnas.93.21.11395.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验